It is also possible that the two prototype FANCC truncating variants analysed here, despite being FA-causing, have reduced penetrance for breast cancer due to some residual function, and other particular FANCC variants may confer a more substantial risk. This evidence concerns the gene FANCC and breast carcinoma.